METHOD FOR PREDICTING THE DURATION OF THE DIARRHEA AND THE SELECTION OF TACTICS OF TREATMENT Russian patent published in 2018 - IPC A61B5/00 A61K31/502 A61P1/00 

FIELD: medicine.

SUBSTANCE: invention relates to the field of medicine, namely to infectious diseases, and can be used to select treatment tactics in patients with acute intestinal infections (AII). Method includes the administration of Galavit in addition to standard etiotropic and pathogenetic therapy, with the content of intestinal interleukin-6 (IL-6) in the coprofilter prior to initiation of therapy. At the level of intestinal IL-6, 1–18 pg/ml predict short-term diarrhea: for 1–3 days, with no therapy Galavit. At the level of IL-6, 19–25 pg/mg predict prolonged diarrhea in patients: from 4 to 10 days, while prescribing Galavit sublingually in a dose of 2 tablets once and then 1 tablet 4 times a day for 4–5 days.

EFFECT: use of the invention makes it possible to improve the accuracy of the prognosis in the early stages of the disease, personify Galavit's appointment to patients with acute intestinal infections and predicted protracted course of the disease, reduce the duration of diarrhea and the duration of general symptoms of the disease.

1 cl, 2 tbl, 4 ex